Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO in ICU patients with pneumonia and thrombocytopenia
NCT05217719Phase 4Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Feb 2022
- Primary completion
- Aug 2023
- Modality
- Cytokines & Interferons
01
Overview
A Phase 4 trial of recombinant human thrombopoietin in Thrombocytopenia, sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
recombinant human thrombopoietin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT05217719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05217719.